Home > Pressrelease > Infection Control Surveillance Solutions Market size to surpass $1.7bn by 2030

Infection Control Surveillance Solutions Market size to surpass $1.7bn by 2030

  • Published Date: August 30, 2022

Infection Control Surveillance Solutions Market size is anticipated to exceed USD 1.7 billion by 2030, according to a new research report by Global Market Insights Inc.

The report identifies increasing technological breakthroughs across the healthcare sector as a promising factor spurring the demand for infection control software during the projection timeframe. The consistent improvements in surveillance technology have enabled healthcare professionals to make better use of such software, paving a way for further advancements across the healthcare industry. For instance, BioMerieux recently launched the CLARION system, a SaaS software-as-a-service enabled solution for infection disease diagnostic, connecting patients' diagnostic data in the US.

Increasing disease burden to boost the adoption of infection control surveillance services

Services segment to expand at a CAGR of more than 13% between 2022 to 2030. This is attributed to the rising prevalence of infectious diseases in recent years. For instance, the COVID-19 infection has affected an estimated 593,269,262 people as of August 2022, resulting in about 6,446,547 deaths, as per the World Health Organization. The increasing disease burden has pushed the demand for infection control surveillance services with better software performance and the ability to detect infections faster, creating new prospects for industry growth.

Browse key industry insights spread across 240 pages with 167 market data tables & 15 figures & charts from the report, “Infection Control Surveillance Solutions Market Size By Component (Software {On-Premise, Web-Based}, Services), By End-user (Hospitals, Clinics, Specialty Centers, Ambulatory Surgical Centers), Industry Analysis Report, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2030.” in detail along with the table of contents:

Availability of quick and precise treatment to foster product demand across clinics

Infection control surveillance solutions market from clinics segment is likely to gain significant impetus over the coming years, anticipated to hold more than 13% of the market share by 2030. Clinics have emerged as an alternative health center among patients with no primary care doctor, seeking quick and precise diagnostic and treatment. These facilities offer a range of services, including diagnosis, prescribing medications, preventive medicine, vaccinations, and school physicals. The availability of skilled medical staff, medical and diagnostic laboratories, and the rapid upsurge in demand for maintaining electronic health records across these settings, will help clinics emerge as prominent end-user for infection control surveillance solutions.

Rising public-private investments to aid the regional landscape

Asia Pacific infection control surveillance solutions market set to reach USD 350 million by 2030. The regional growth can be credited to the emerging investments from public and private players to create awareness about infection prevention across the regional economies. The growing burden of infectious and chronic ailments has encouraged countries in the Asia Pacific to collaborate with global policymakers to implement measures to mitigate community transmissions associated with the diseases.

For instance, during the pandemic, UNICEF reached 1.2 million people in Malaysia through social media messaging and conducted a U-report poll on 678 adolescents. The poll revealed that about 64% of them were grappling with negative emotions like loneliness, boredom, and frustration following the movement restriction mandate. The increasing focus of major players to capture a significant share in the Asia Pacific market may help the regional industry flourish in the years to come.

Technological advancements to boost the competitive outlook

Notable players in the infection control surveillance solutions market include Baxter International Inc., Premier, Inc., Cerner Corporation, Becton, Dickinson, and Company, GOJO Industries, Inc., Sunquest, IBM Corporation, OASIS Medical, Ecolab Inc., Harris Healthcare, CenTrak, Inc., Roper Technologies. These companies have been focusing on leveraging cutting-edge technologies to introduce advanced products in their portfolio and gain dominance in the global market.

 For instance, in November 2019, BD announced the integration of enhanced antimicrobial stewardship surveillance analytics into its HealthSight connected medication management platform to help combat antimicrobial resistance (AMR). The analytics based on a patient's specific infection diagnosis identifies a potentially ineffective and inappropriate antibiotic that has been prescribed.

Authors: Sumant Ugalmugle, Rupali Swain